MX368621B - Solucion acuosa clara. - Google Patents
Solucion acuosa clara.Info
- Publication number
- MX368621B MX368621B MX2015009895A MX2015009895A MX368621B MX 368621 B MX368621 B MX 368621B MX 2015009895 A MX2015009895 A MX 2015009895A MX 2015009895 A MX2015009895 A MX 2015009895A MX 368621 B MX368621 B MX 368621B
- Authority
- MX
- Mexico
- Prior art keywords
- aqueous solution
- clear aqueous
- formula
- c6h5ch2n
- benzisoxazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La presente invención proporciona una preparación líquida acuosa y estable que contiene ácido (3-{2-[4-isopropil-2-(4-trifluorometi l)fenil-5-tiazolil]etil}-5-metil-1,2-bencisoxazol-6-il)oxiacético o una sal farmacéuticamente aceptable del mismo como un ingrediente activo, y cloruro de benzalconio representado por la fórmula: [C6H5CH2N(CH3)2R)Cl en donde R es un grupo alquilo que tiene de 8 a 18 átomos de carbono.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013017876 | 2013-01-31 | ||
JP2013267724 | 2013-12-25 | ||
PCT/JP2014/052041 WO2014119643A1 (ja) | 2013-01-31 | 2014-01-30 | 澄明な水性液剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015009895A MX2015009895A (es) | 2015-09-24 |
MX368621B true MX368621B (es) | 2019-10-08 |
Family
ID=51262354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015009895A MX368621B (es) | 2013-01-31 | 2014-01-30 | Solucion acuosa clara. |
Country Status (10)
Country | Link |
---|---|
US (2) | US9968679B2 (es) |
EP (1) | EP2952189B1 (es) |
JP (1) | JP5753958B2 (es) |
KR (1) | KR20150110773A (es) |
CN (1) | CN105025896B (es) |
BR (1) | BR112015017919A8 (es) |
CA (1) | CA2899237A1 (es) |
MX (1) | MX368621B (es) |
RU (1) | RU2662067C2 (es) |
WO (1) | WO2014119643A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105007918B (zh) * | 2013-01-31 | 2018-06-15 | 千寿制药株式会社 | 稳定的水性液体制剂 |
KR20200100676A (ko) | 2017-12-20 | 2020-08-26 | 이에이 파마 가부시키가이샤 | 유지 투석 하의 2차성 부갑상선 기능 항진증의 예방 또는 치료용 의약 조성물 |
US20220142958A1 (en) * | 2019-04-03 | 2022-05-12 | Ea Pharma Co., Ltd. | Medicinal composition having excellent stability |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0283318A (ja) | 1988-09-20 | 1990-03-23 | Zeria Pharmaceut Co Ltd | 安定な点眼剤 |
JP4171529B2 (ja) | 1995-06-26 | 2008-10-22 | 大正製薬株式会社 | 点眼剤の充填容器 |
JPH11228404A (ja) | 1997-12-11 | 1999-08-24 | Senju Pharmaceut Co Ltd | 安定な水性点眼剤 |
CN1228053C (zh) * | 2001-09-11 | 2005-11-23 | 参天制药株式会社 | 含有二尿苷磷酸的滴眼液 |
JP2003160491A (ja) * | 2001-09-11 | 2003-06-03 | Santen Pharmaceut Co Ltd | ジウリジンリン酸含有点眼液 |
MXPA04003398A (es) | 2001-10-12 | 2004-11-22 | Nippon Chemiphar Co | Activador para el receptor o activado con el proliferador de peroxisoma. |
JP4402591B2 (ja) | 2002-07-16 | 2010-01-20 | 千寿製薬株式会社 | 薬液容器及びその製造方法 |
JP2004123729A (ja) * | 2002-09-09 | 2004-04-22 | Santen Pharmaceut Co Ltd | ラタノプロストを有効成分とする澄明な点眼液 |
CA2707067C (en) | 2002-09-09 | 2013-07-16 | Santen Pharmaceutical Co., Ltd. | Clear ophthalmic solution comprising latanoprost as active ingredient |
CN101278936B (zh) * | 2002-09-09 | 2012-10-31 | 参天制药株式会社 | 含有效成分拉坦前列素的澄明滴眼剂 |
US8129431B2 (en) | 2003-01-21 | 2012-03-06 | Senju Pharmaceutical Co., Ltd. | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
EP2151438B1 (en) * | 2007-05-21 | 2012-10-31 | Senju Pharmaceutical Co., Ltd. | Pharmaceutical containing ppar-delta agonist |
AU2008329876A1 (en) | 2007-11-27 | 2009-06-04 | Alcon Research, Ltd. | Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate |
WO2011034192A1 (ja) * | 2009-09-17 | 2011-03-24 | 千寿製薬株式会社 | ラタノプロストを含有する水性点眼剤、並びにラタノプロストの樹脂への吸着の抑制方法 |
CN105007918B (zh) | 2013-01-31 | 2018-06-15 | 千寿制药株式会社 | 稳定的水性液体制剂 |
CN204146320U (zh) | 2014-06-06 | 2015-02-11 | 黄金珍 | 电子烟雾化器 |
-
2014
- 2014-01-30 CA CA2899237A patent/CA2899237A1/en not_active Abandoned
- 2014-01-30 EP EP14745555.4A patent/EP2952189B1/en active Active
- 2014-01-30 JP JP2014559730A patent/JP5753958B2/ja not_active Expired - Fee Related
- 2014-01-30 BR BR112015017919A patent/BR112015017919A8/pt not_active IP Right Cessation
- 2014-01-30 WO PCT/JP2014/052041 patent/WO2014119643A1/ja active Application Filing
- 2014-01-30 KR KR1020157023168A patent/KR20150110773A/ko not_active Application Discontinuation
- 2014-01-30 CN CN201480007082.0A patent/CN105025896B/zh not_active Expired - Fee Related
- 2014-01-30 US US14/763,304 patent/US9968679B2/en not_active Expired - Fee Related
- 2014-01-30 RU RU2015135974A patent/RU2662067C2/ru not_active IP Right Cessation
- 2014-01-30 MX MX2015009895A patent/MX368621B/es active IP Right Grant
-
2018
- 2018-04-16 US US15/953,557 patent/US10709786B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20150366969A1 (en) | 2015-12-24 |
US9968679B2 (en) | 2018-05-15 |
BR112015017919A2 (pt) | 2017-07-11 |
EP2952189A1 (en) | 2015-12-09 |
KR20150110773A (ko) | 2015-10-02 |
CN105025896B (zh) | 2017-11-14 |
BR112015017919A8 (pt) | 2019-11-05 |
WO2014119643A1 (ja) | 2014-08-07 |
RU2015135974A (ru) | 2017-03-03 |
EP2952189B1 (en) | 2019-09-18 |
MX2015009895A (es) | 2015-09-24 |
CN105025896A (zh) | 2015-11-04 |
EP2952189A4 (en) | 2016-08-31 |
JPWO2014119643A1 (ja) | 2017-01-26 |
CA2899237A1 (en) | 2014-08-07 |
US10709786B2 (en) | 2020-07-14 |
US20180228901A1 (en) | 2018-08-16 |
JP5753958B2 (ja) | 2015-07-22 |
RU2662067C2 (ru) | 2018-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502232A1 (en) | Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists | |
RS54526B1 (en) | USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS | |
IN2014MN01897A (es) | ||
PH12015500209A1 (en) | Partially saturated nitrogen-containing heterocyclic compound | |
PH12015502031B1 (en) | Tetrahydropyrrolothiazine compounds | |
PH12015501993A1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
MX2016006336A (es) | Compuestos pirazolopirimidina. | |
RS54730B1 (sr) | Inhibitori beta sekretaze | |
MD20140072A2 (ro) | Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
MX2019009100A (es) | Nuevos derivados de triazolo[4,5-d]pirimidina. | |
MX2016007861A (es) | Compuestos de ácido dimetilbenzoico. | |
MX2014002552A (es) | Compuesto pirazol y su uso farmaceutico. | |
JO3318B1 (ar) | مثبطات bace | |
PH12015502178A1 (en) | Pyridinylpyrazoloquinoline compound | |
MX2015015841A (es) | Compuestos de fenoxietil dihidro-1h-isoquinolina. | |
NZ712660A (en) | Dicarboxylic acid compound | |
IN2014DN10669A (es) | ||
MX368621B (es) | Solucion acuosa clara. | |
MX359399B (es) | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. | |
MX365408B (es) | Solución acuosa estable. | |
MX355654B (es) | Derivado de paroxetina. | |
MX358151B (es) | Derivado de sitaxentan. | |
EA201400269A1 (ru) | Способ синтеза соединений 7,8-диметокси -1,3-дигидро-2h-3-бензазепин-2-она и применение в синтезе ивабрадина | |
RU2015115328A (ru) | Замещенные 1,2,5-триметил- и 2,2,6,6-тетраметил-4-аминопиперидины, обладающие антиишемическим действием |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |